Anna Trauzold
Impact in
- Cancer Research top 2%
- NF-κB Signaling Pathways
- Immunology top 5%
- interferon and immune responses
- Phagocytosis and Immune Regulation
Papers in
-
- Cell death mechanisms and regulation 37
- Oncology 36
- Pancreatic and Hepatic Oncology Research 14
- Cancer-related Molecular Pathways 13
- Co-authors
- Holger Kalthoff (38 shared papers)Christian Röder (19 shared papers)Alexander Arlt (10 shared papers)Harald Wajant (7 shared papers)H. Schäfer (13 shared papers)Hendrik Ungefroren (7 shared papers)Stefan Schütze (5 shared papers)Bodo Schniewind (5 shared papers)
- Journals
- Cancers (5 papers)Oncogene (5 papers)Annals of the New York Academy of Sciences (4 papers)Cell Death and Disease (4 papers)Oncotarget (3 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Anna Trauzold
72 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 715
- Immunology 844
- Oncology 960
- Molecular Biology 2.0k
- Biotechnology 118
Countries citing papers authored by Anna Trauzold
This map shows the geographic impact of Anna Trauzold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Trauzold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Trauzold more than expected).
Fields of papers citing papers by Anna Trauzold
This network shows the impact of papers produced by Anna Trauzold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Trauzold. The network helps show where Anna Trauzold may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Trauzold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 281 | |
| 2 | 2000 | 213 | |
| 3 | 2008 | 211 | |
| 4 | 2006 | 183 | |
| 5 | 2001 | 139 | |
| 6 | 2011 | 90 | |
| 7 | 2010 | 85 | |
| 8 | 2008 | 84 | |
| 9 | 2005 | 78 | |
| 10 | 2010 | 69 | |
| 11 | 2003 | 69 | |
| 12 | 2001 | 68 | |
| 13 | 2019 | 62 | |
| 14 | 1998 | 61 | |
| 15 | 2003 | 54 | |
| 16 | 2014 | 51 | |
| 17 | 2014 | 49 | |
| 18 | PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line. | 1996 | 48 |
| 19 | 2007 | 44 | |
| 20 | 2016 | 44 |
About Anna Trauzold
Anna Trauzold is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Biotechnology, having authored 72 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (37 papers), Phagocytosis and Immune Regulation (14 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cancer-related Molecular Pathways (13 papers), Cancer Research and Treatments (10 papers), NF-κB Signaling Pathways (10 papers), interferon and immune responses (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (715 citations), Immunology (844 citations), Oncology (960 citations), Molecular Biology (2.0k citations) and Biotechnology (118 citations). Anna Trauzold has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Holger Kalthoff, Christian Röder, Alexander Arlt, Harald Wajant, H. Schäfer, Hendrik Ungefroren, Stefan Schütze, Bodo Schniewind, Jan‐Hendrik Egberts and Michael Heinrich. Their work appears in journals such as Cancers, Oncogene, Annals of the New York Academy of Sciences, Cell Death and Disease and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.